Novo Nordisk (NVO) Taps Anthropic AI to Develop Next-Generation Medicines

Covered by 4 sources
Read full post
Novo Nordisk has partnered with Anthropic to leverage AI in accelerating the development of next-generation medicines, aiming to enhance drug discovery speed and efficiency.

Covered by 4 sources


More in Healthcare

Novo Will Work With Anthropic AI to Speed Drug Development

Covered by 4 sources
Healthcare3 min read

Advanced quantitative mapping of Alzheimer’s disease neuropathology and microglial activation in post-mortem hippocampal tissue

Nature
Healthcare19 min read

Improving HCLS AI reasoning with open-source agent skills

AWS Blog